Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Balchem (BCPC) EBIT (2016 - 2025)

Balchem (BCPC) has disclosed EBIT for 16 consecutive years, with $52.3 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT rose 10.21% to $52.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $209.3 million, a 14.44% increase, with the full-year FY2025 number at $209.3 million, up 14.44% from a year prior.
  • EBIT was $52.3 million for Q4 2025 at Balchem, down from $54.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $54.6 million in Q3 2025 to a low of $30.6 million in Q1 2021.
  • A 5-year average of $41.2 million and a median of $40.8 million in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: surged 30.49% in 2022, then decreased 10.25% in 2023.
  • Balchem's EBIT stood at $33.8 million in 2021, then decreased by 1.53% to $33.3 million in 2022, then grew by 15.1% to $38.3 million in 2023, then grew by 23.76% to $47.4 million in 2024, then grew by 10.21% to $52.3 million in 2025.
  • Per Business Quant, the three most recent readings for BCPC's EBIT are $52.3 million (Q4 2025), $54.6 million (Q3 2025), and $51.4 million (Q2 2025).